2026-09-20T09:42:46Zhttps://dspace.mit.edu/server/oai/requestoai:dspace.mit.edu:1721.1/1075172026-06-06T01:03:24Zcom_1721.1_7582com_1721.1_7581col_1721.1_131023
Jarrod Goentzel.
Kamareddine, Karim
Yao, Yihong
Massachusetts Institute of Technology. Engineering Systems Division.
Massachusetts Institute of Technology. Supply Chain Management Program
2017-03-20T19:38:01Z
2017-03-20T19:38:01Z
2016
2016
http://hdl.handle.net/1721.1/107517
962735989
Thesis: M. Eng. in Logistics, Massachusetts Institute of Technology, Supply Chain Management Program, 2016.
Cataloged from PDF version of thesis.
Includes bibliographical references (pages 46-47).
Large pharmaceutical companies struggle to find innovative ways to reduce work-in-process inventory in their production facilities. In our research, we focus on the tradeoff between inventory and production capacity through investing in new facilities and equipment. This tradeoff will depend on the company's objectives and what it is willing to give up in return for reducing inventory. We found that increasing capacity to reduce work-in-process inventory by investing in new facilities is not always the most favorable approach in terms of net present value. However, for flexibility or lead-time improvements, it may make sense to proceed with the investment. We developed multiple scenarios considering the company's future plans to reduce inventory or grow. These scenarios provide insights into the factors that improve the attractiveness of the investments and those that do not. Our financial analysis along with the guidelines and procedures that we have developed help the sponsor company most effectively reach its goal to reduce its work in process inventory.
by Karim Kamareddine and Yihong Yao.
M.Eng. in Logistics
47 pages
eng
Massachusetts Institute of Technology
MIT theses may be protected by copyright. Please reuse MIT thesis content according to the MIT Libraries Permissions Policy, which is available through the URL provided.
http://dspace.mit.edu/handle/1721.1/7582
Supply Chain Management Program.
Engineering Systems Division.
Analyzing tradeoffs between working capital and production capacity for multi-stage manufacturing processes
Thesis
application/pdf
false
Publication
unknown
unknown
<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="a496f0e1-3209-42bd-9d14-4b1fadc325f6">
<Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type>
<Language>eng</Language>
<Title>Analyzing tradeoffs between working capital and production capacity for multi-stage manufacturing processes</Title>
<PublishedIn>
<Publication>
</Publication>
</PublishedIn>
<PublicationDate>2016</PublicationDate>
<Authors>
<Author>
<DisplayName>Kamareddine, Karim</DisplayName>
<Affiliation>
<OrgUnit>
</OrgUnit>
</Affiliation>
</Author>
<Author>
<DisplayName>Yao, Yihong</DisplayName>
<Affiliation>
<OrgUnit>
</OrgUnit>
</Affiliation>
</Author>
</Authors>
<Editors>
</Editors>
<Publishers>
<Publisher>
<DisplayName>Massachusetts Institute of Technology</DisplayName>
<OrgUnit />
</Publisher>
</Publishers>
<License>http://dspace.mit.edu/handle/1721.1/7582</License>
<Keyword>Supply Chain Management Program.</Keyword>
<Keyword>Engineering Systems Division.</Keyword>
<Abstract>Large pharmaceutical companies struggle to find innovative ways to reduce work-in-process inventory in their production facilities. In our research, we focus on the tradeoff between inventory and production capacity through investing in new facilities and equipment. This tradeoff will depend on the company's objectives and what it is willing to give up in return for reducing inventory. We found that increasing capacity to reduce work-in-process inventory by investing in new facilities is not always the most favorable approach in terms of net present value. However, for flexibility or lead-time improvements, it may make sense to proceed with the investment. We developed multiple scenarios considering the company's future plans to reduce inventory or grow. These scenarios provide insights into the factors that improve the attractiveness of the investments and those that do not. Our financial analysis along with the guidelines and procedures that we have developed help the sponsor company most effectively reach its goal to reduce its work in process inventory.</Abstract>
<Access xmlns="http://purl.org/coar/access_right"
>
</Access>
</Publication>